Literature shows strong evidence on high levels of circulating PlGF in individuals with various diseases such as cancer (breast, melanoma, leukemia), auto-immune diseases (rheumatoid arthritis, Systemic Lupus Erythematosus), coronary heart disease, and neovascular age-related macular degeneration. This evidence concerns the gene PGF and systemic lupus erythematosus.